DK0483614T3 - Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv - Google Patents

Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv

Info

Publication number
DK0483614T3
DK0483614T3 DK91117799.6T DK91117799T DK0483614T3 DK 0483614 T3 DK0483614 T3 DK 0483614T3 DK 91117799 T DK91117799 T DK 91117799T DK 0483614 T3 DK0483614 T3 DK 0483614T3
Authority
DK
Denmark
Prior art keywords
amino acids
metabolically
protect
heart tissue
ischemic heart
Prior art date
Application number
DK91117799.6T
Other languages
English (en)
Inventor
David Madsen
Gary Pace
Bruce Rowe
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24423981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0483614(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of DK0483614T3 publication Critical patent/DK0483614T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91117799.6T 1990-10-30 1991-10-18 Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv DK0483614T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60551490A 1990-10-30 1990-10-30

Publications (1)

Publication Number Publication Date
DK0483614T3 true DK0483614T3 (da) 1995-10-30

Family

ID=24423981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91117799.6T DK0483614T3 (da) 1990-10-30 1991-10-18 Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv

Country Status (9)

Country Link
EP (1) EP0483614B1 (da)
JP (1) JPH04264024A (da)
AT (1) ATE123941T1 (da)
AU (1) AU655780B2 (da)
CA (1) CA2054134A1 (da)
DE (1) DE69110615T2 (da)
DK (1) DK0483614T3 (da)
ES (1) ES2074623T3 (da)
GR (1) GR3017321T3 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
DE69637676D1 (de) * 1995-11-09 2008-10-23 Univ R Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
TWI266614B (en) 2000-10-13 2006-11-21 Chugai Pharmaceutical Co Ltd Compositions comprising valine for improving lipid metabolism
ITTO20010580A1 (it) * 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2008056566A (ja) * 2004-12-28 2008-03-13 Toudai Tlo Ltd 低酸素応答促進剤
US20170128412A1 (en) * 2015-08-11 2017-05-11 Satoru Sugiyama System and method for improved blood circulation and maintaining mitochondrial energy production
JP6838752B2 (ja) * 2019-08-30 2021-03-03 株式会社東洋新薬 血流改善組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228127A1 (de) * 1982-07-28 1984-02-02 Basf Ag, 6700 Ludwigshafen Aminosaeuren-infusionsloesungen
IL83822A0 (en) * 1986-09-10 1988-02-29 Dudrick Medical Research Fund Compositions for treating atherosclerosis comprising biologically active amino acids

Also Published As

Publication number Publication date
DE69110615T2 (de) 1995-12-14
ES2074623T3 (es) 1995-09-16
AU8567091A (en) 1992-05-07
DE69110615D1 (de) 1995-07-27
JPH04264024A (ja) 1992-09-18
EP0483614A1 (en) 1992-05-06
GR3017321T3 (en) 1995-12-31
EP0483614B1 (en) 1995-06-21
CA2054134A1 (en) 1992-05-01
ATE123941T1 (de) 1995-07-15
AU655780B2 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
FI844510A0 (fi) Ensym-resistenta immunsystemet modulerande peptider.
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
SE8703625D0 (sv) New medical use
NO885797L (no) Karboksylsyrederivater med terapeutisk virkning og fremgangsmaate til deres fremstilling.
IE791235L (en) Acyl-derivatives of carnitine.
DK0483614T3 (da) Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv
NO155239C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, blandede salter av essensielle eller semi-essensielle aminosyrer og nitrogenfri analoger derav.
DK0639979T3 (da) Ligand for c-kit-receptoren og fremgangsmåde til anvendelse heraf
NO146599C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 6-klor-2-(1`-piperazinyl)-pyrazin og salter derav
NO995944L (no) Anti-arrytmisk blanding og fremgangsmåter for behandling
EP0199117A3 (en) New therapeutical use of phosphocreatine
ATE145825T1 (de) Behandlung von erhöhtem blutdruck
NO177859C (no) Fremgangsmåte til produksjon av angiogen faktor
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
LV10384A (lv) Sastavs asins plazmas stabilizacijai pasterizacijas laika
SE7702251L (sv) Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol
DK338583A (da) Fremgangsmaade og medikament til reduktion af vaevslaesioner i et dyr
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
ATE68474T1 (de) Aktive substanz in der kardiovaskulaeren therapie.
ZM2875A1 (en) N-(1'-allylpyrrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide, its pharmaceutically acceptable addition salts with acids and methods for its preparation
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
SE8401907D0 (sv) New phenoxypropanol amine salts and pharmaceutical preparations thereof
NL7411979A (en) (1-Alpha-aminoisobutyric acid)-c9is - with higher potencies than natural ACTH
杨甲三 INDICATIONS FOR THE APPLICATION AND COMBINED USE OF ACUPOINTS OF THE 14 MAJOR CHANNELS